pocketful logo light
pocketful logo light
Aarti Pharmalabs Ltd logo

Aarti Pharmalabs Ltd

NSE: AARTIPHARM BSE: 543748

825.75

(0.47%)

Sun, 20 Sept 2026, 11:44 am

Aarti Pharmalabs Share Price Live Chart

1 Day

(0.47%)

No Result Found

Summary

  • Market Cap (in Cr)

    5754.5

  • Net Profit (in Cr)

    272.4

  • P/B

    3.41

  • Sector P/E

    33.76

  • P/E

    24.90

  • EV/EBITDA

    15.15

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    14.54

  • ROCE

    17.35

  • Debt/Equity

    0.19

  • EPS (TTM)

    19.50

  • Dividend Yield

    0.55

  • Book Value

    234.35

  • Interest Cover

    14.41

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters43.0843.1042.8843.7244.29
FII8.397.688.027.357.36
DII7.417.666.967.797.53
Public41.1141.5442.1341.1240.81
Government0.010.010.010.010.01

Read More

Technical Analysis

RSI

50.25

MACD

8.02

50 DMA

779.42

200 DMA

725.44

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1340.121078.17961.78816.22699.83554.27292.32
Fibonacci1078.17978.10916.28816.22716.15654.33554.27
Camarilla917.44893.42869.41816.22821.39797.38773.36

Pivots Level: Classic

R3

+523.90

1340.12

R2

+261.95

1078.17

R1

+145.57

961.78

816.22
816.22
Pivot Point
LTP: 820.40

S1

-116.38

699.83

S2

-261.95

554.27

S3

-523.90

292.32

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    827.27

  • 20-EMA

    826.61

  • 30-EMA

    815.76

  • 50-EMA

    791.91

  • 100-EMA

    759.10

  • 200-EMA

    746.43

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
25 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
18 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
09 Feb 2026board-meetingsQuarterly Results, Interim Dividend
09 Feb 2026dividend₹1.50 Dividend /Share16 Feb 2026
16 Jan 2026dividendInterim Dividend - Rs. - 1.516 Feb 2026
09 Nov 2025board-meetingsQuarterly Results
29 Aug 2025agm
15 Aug 2025dividendFinal Dividend - Rs. - 2.515 Sept 2025
10 May 2025dividend₹2.50 Dividend /Share15 Sept 2025
05 Feb 2025dividend₹2.50 Dividend /Share14 Feb 2025

Read More

Peer Comparison

Aarti Pharmalabs Ltd logo

Aarti Pharmalabs Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Aarti Pharmalabs Ltd About

Aarti Pharmalabs The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2019

Headquarters

CEO

Rashesh C Gogri

Employees

Contact

Website icon

Website

https://www.aartipharmalabs.com

Email icon

Email

co.apl@aartipharmalabs.com ; investorrelations@aar

Phone icon

Phone

91-22-6797 6666

Location icon

Location

Plot No 22/C/1 & 22/C/2, 1st Phase GIDC Vapi, Valsad, Gujarat, 396195

Read More

Aarti Pharmalabs Ltd Company History

YearHistory
2019
  • The Company was incorporated as a public limited company under the Companies Act, 2013.
2021
  • The Company name was changed from Aarti Organics Limited to Aarti Pharmalabs Limited.
2022
  • NCLT approved the Scheme of Arrangement between Aarti Industries Limited and Aarti Pharmalabs Limited.
  • Pharma business of Aarti Industries Limited was vested into the Company.
2025
  • Aarti Pharmalabs Ltd. Credit Rating was upgraded to CRISIL AA-/Stable.
  • Aarti Pharmalabs earned an EcoVadis Gold Rating for sustainability.
  • Aarti Pharmalabs achieved a key sustainability milestone with approval of GHG Emission Reduction Targets by SBTi.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIFbulkBuy521613930.3419 Sept 2025
NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBALbulkBuy484643930.3219 Sept 2025
SAFECHEM ENTERPRISES PRIVATE LIMITEDbulkSell600000929.1919 Sept 2025
BNP PARIBAS FINANCIAL MARKETSbulkSell45943892919 Sept 2025
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDbulkBuy561058930.3419 Sept 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell848700742.1907 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy848700742.0407 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy854861706.6806 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell854861704.9406 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy776227675.1727 Dec 2024

Read More

Aarti Pharmalabs Ltd News

Aarti Pharma Labs shares flag large-trade signal

A large-trade signal flagged approximately 765,697 shares of Aarti Pharma Labs on NSE at ₹821.9 per share, with a combined value of ₹62.93 crore.

18 Sept 2026

equity-markets

Aarti Pharmalabs expands capacity with new Tarapur block

Aarti Pharmalabs inaugurated a new manufacturing block at Tarapur Unit 5, Maharashtra, adding 3600 TPA capacity for Xanthine derivatives. This expansion increases total capacity to 9600 TPA.

30 Jun 2026

companies

Aarti Pharma Labs Q4 Profit Falls to 611M Rupees YoY

Aarti Pharma Labs reports Q4 consolidated net profit of 611M Rupees vs 883M YoY. EBITDA declined to 1.1B Rupees; margin contracted to 19.42% from 25.39%.

25 May 2026

companies

AARTI PHARMALABS investor meeting on May 28

AARTI PHARMALABS LIMITED will meet investors and analysts on May 28, 2026, at the 360 ONE Capital Conference. The meeting will be held in physical mode.

20 May 2026

companies

Aarti Pharmalabs Q4 FY26 call

Aarti Pharmalabs Limited has scheduled an earnings conference call for May 26, 2026, to discuss its Q4 FY26 financial results. The meeting will be held at 4:00 PM IST.

20 May 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Aarti Pharmalabs Ltd?

    As of 20/09/2026 at 5:14 PM, Aarti Pharmalabs Ltd shares are trading at 825.75.

  • 2.What is the market cap. of Aarti Pharmalabs Ltd?

    As of 20/09/2026, the market capitalization of Aarti Pharmalabs Ltd is 7,524.16 crore.

  • 3.When was Aarti Pharmalabs Ltd founded?

    Aarti Pharmalabs Ltd was founded in 2019.

  • 4.What are the P/E and P/B ratios of Aarti Pharmalabs Ltd?

    As of 20/09/2026, Aarti Pharmalabs Ltd has a P/E ratio of 35.13 and a P/B ratio of 3.41.

  • 5.How can I buy shares of Aarti Pharmalabs Ltd?

    You can buy shares of Aarti Pharmalabs Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Aarti Pharmalabs Ltd?

    As of March,2026, promoters hold 43.08% in Aarti Pharmalabs Ltd, while FIIs, DIIs and public shareholders hold 8.39%, 7.41% and 41.11%, respectively. The government holds 0.01%.

  • 7.Does Aarti Pharmalabs Ltd pay dividends?

    Yes, Aarti Pharmalabs Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹1.50 Dividend /Share per share.

  • 8.What is the dividend yield of Aarti Pharmalabs Ltd?

    As of 20 September, 2026, the dividend yield of Aarti Pharmalabs Ltd stands at 0.48%.

  • 9.What are the latest financial results of Aarti Pharmalabs Ltd?

    For January,2024, Aarti Pharmalabs Ltd reported revenue of 2,088.00 crore and a net profit of 272.00 crore.

  • 10.What is the Stock symbol of Aarti Pharmalabs Ltd?

    AARTIPHARM is the stock symbol of Aarti Pharmalabs Ltd.

  • 11.Who is the CEO of Aarti Pharmalabs Ltd?

    The CEO of Aarti Pharmalabs Ltd is Rashesh C Gogri.

Open Your Free Demat Account

Enter your phone number